Louis Sterling III
About Louis Sterling III
Louis Sterling III (age 46) has served as an independent, non-executive director of Amarin since February 2023. He is Chair of the Nominating & Corporate Governance Committee and a member of the Audit Committee. Sterling is a private investor (since 2017) with prior experience in investment banking (Goldman Sachs), middle-market private equity (Lincolnshire Management), and as a managing director at BondFactor. He holds a J.D. (Harvard Law School), M.B.A. (Harvard Business School), and B.B.A. (Howard University) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Private Investor | Investor in small-cap public equities and growth private companies (focus: healthcare) | Jan 2017–present | Capital allocation and M&A expertise |
| Goldman Sachs | Investment Banking (Corporate Finance/M&A) | Pre-2017 (dates not specified) | Transaction execution experience |
| Lincolnshire Management | Middle-market Private Equity | Pre-2017 (dates not specified) | Portfolio and value-creation experience |
| BondFactor | Managing Director | Pre-2017 (dates not specified) | Operating/leadership experience |
| BZAM Ltd. (formerly The Green Organic Dutchman Holdings Ltd.) | Director; Chair, Corporate Governance & Nominating; Member, Compensation | Dec 2021–Apr 2023 | Chaired governance; comp committee member |
External Roles
- The Amarin proxy does not list any current public company directorships for Mr. Sterling as of the filing date .
Board Governance
- Independence: The Board determined all directors other than the CEO (Mr. Berg) are independent; Sterling is independent .
- Board structure: Independent Chair (Dr. Odysseas Kostas). Independent directors meet at every Board meeting .
- Board declassified: Classified board eliminated in 2024; all directors now stand for annual election .
- Meetings and attendance: Board met 10 times in 2024; each director attended at least 75% of aggregate Board and committee meetings of which they were a member .
| Committee | Role | Independence | 2024 Meetings |
|---|---|---|---|
| Audit Committee | Member (Chair: Keith L. Horn) | All members independent; “audit committee financial expert” designation for Horn and Bonfiglio (not Sterling) | 9 |
| Nominating & Corporate Governance Committee | Chair | All members independent | 4 |
Fixed Compensation
- Cash retainer program (2024):
| Retainer Component | Amount (USD) |
|---|---|
| Non-Executive Chairman annual board retainer | $95,000 |
| All non-employee directors annual board retainer | $62,500 |
| Audit Committee Chair | $25,000 |
| Remuneration Committee Chair | $20,000 |
| Nominating & Corporate Governance Committee Chair | $11,000 |
| Audit Committee member | $12,000 |
| Remuneration Committee member | $10,000 |
| Nominating & Corporate Governance Committee member | $5,000 |
-
Directors may elect to receive retainers in cash or unregistered ordinary shares each quarter (priced as defined) .
-
2024 actual compensation for Mr. Sterling:
| Component (FY 2024) | Amount (USD) |
|---|---|
| Fees Earned or Paid in Cash | $58,803 |
| Stock Awards (grant-date fair value) | $43,750 |
| Option Awards (grant-date fair value) | $131,250 |
| Total | $233,803 |
Performance Compensation
- Equity award policy for non-employee directors (revised Feb 2024):
- Annual grant fair value: $175,000; 75% stock options / 25% RSUs .
- Vesting: Options vest annually over three years; RSUs vest annually over three years (no deferred settlement) .
- New director initial grant (as revised Feb 2024): $262,500; options vest 1/3 at 1 year, then quarterly over next 2 years; RSUs vest annually over three years .
- Change in control: All equity awards held by non-employee directors fully vest upon a change of control .
- Note: The proxy does not disclose performance metrics (e.g., TSR, revenue) tied to director equity; awards are service-based, not performance-conditioned .
Other Directorships & Interlocks
| Company | Role | Timeframe | Committees |
|---|---|---|---|
| BZAM Ltd. | Director | Dec 2021–Apr 2023 | Chair, Corporate Governance & Nominating; Member, Compensation |
- AMRN Board composition reflects shareholder-influenced refresh (e.g., Sarissa-associated directors serve; one Sarissa-linked director not standing for re-election in 2025), indicating active investor engagement and evolving governance dynamics .
Expertise & Qualifications
- Education: J.D. (Harvard Law School), M.B.A. (Harvard Business School), B.B.A. (Howard University) .
- Domain expertise emphasized by the Board: investments, operations, capital allocation, corporate finance, and M&A .
- Years on AMRN board: since 2023 (standing for annual re-election) .
Equity Ownership
| Holder | Shares Beneficially Owned | Percent of Class | Notes |
|---|---|---|---|
| Louis Sterling III | 499,511 | <1% (*) | As of Feb 28, 2025; percent computed on 414,186,296 shares; “*” indicates less than 1% per proxy . |
Equity detail as of Dec 31, 2024 (director holdings):
| Instrument | Quantity |
|---|---|
| Unexercised Unvested Stock Options | 369,527 |
| Unexercised Vested Stock Options | 262,277 |
| Unvested Stock Awards (RSUs) | 113,531 |
| Vested but Deferred Stock Awards | 87,426 |
Ownership alignment policies:
- Director ownership guideline: at least 3x annual cash retainer; directors elected in 2023 (including Sterling) have until 2028 to comply .
- Anti-hedging/anti-pledging: Hedging and pledging prohibited without Audit Committee approval; policy governs directors and executives .
- Section 16(a) compliance: Company disclosed administrative late filings for certain officers (Berg, Ketchum, Reilly); no late filings indicated for Mr. Sterling in 2024 .
Governance Assessment
-
Strengths
- Independent director with M&A and capital allocation experience; chairs Nominating & Corporate Governance and serves on Audit—positions central to board effectiveness .
- Board/committee cadence robust (Board: 10; Audit: 9; N&G: 4 in 2024), with each director meeting at least 75% attendance—supports engagement .
- Equity-heavy director pay (75% options / 25% RSUs) and ownership guideline (3x retainer by 2028) align incentives with investors .
- No related-party transactions involving directors reported since Jan 1, 2024; strong insider trading/anti-pledge controls .
-
Watch items / potential red flags
- Director equity vests immediately upon change of control—single-trigger acceleration can be shareholder-unfriendly if not balanced by other protections .
- Attendance disclosed only as “≥75%” across directors; absence of individual attendance detail limits transparency on director-specific engagement .
- Say-on-pay support in 2024 at ~79.5% reflects moderate shareholder support, not a failure, but still below typical high-80s/90s levels for many peers .
-
Shareholder sentiment and responsiveness
- Annual say-on-pay supported by ~79.5% in 2024; Board increased outreach, retained an independent consultant (Pearl Meyer) for 2024 compensation design; Remuneration Committee revised director equity structure and size (with Aon input previously) to align around peer medians—signals responsiveness to investor feedback .
Notes on Data Gaps
- Recent insider Form 4 transaction details for Mr. Sterling could not be retrieved programmatically due to an authorization error in the insider-trades tool. This report relies on the proxy’s beneficial ownership and equity holdings tables for ownership analysis .